MedTrace Logo

Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation

NCT03545503 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 428

Last updated 2021-11-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the hemodynamic effects of ketamine v etomidate during rapid sequence intubation (RSI) in the pre-hospital and emergency department setting.

Conditions

  • Intubation Complication

Interventions

DRUG

Etomidate

Etomidate will be administered as the sedative for RSI on even days

DRUG

Ketamine

Ketamine will be administered as the sedative for RSI on odd days

Sponsors & Collaborators

  • New Hanover Regional Medical Center

    collaborator OTHER

  • South East Area Health Education Center, Wilmington, NC

    lead OTHER

Principal Investigators

  • William F Powers IV, MD · New Hanover Regional Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-09-01
Completion
2019-09-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03545503 on ClinicalTrials.gov